Integral Diagnostics (ASX:IDX) is engaging with the Australian Competition and Consumer Commission (ACCC) regarding the potential divestment of Capitol Health's (ASX:CAJ) Melton clinic in Victoria, contingent on the implementation of its proposed merger with the company, according to a Monday filing with the Australian bourse.

The clinic's financial contribution to Capitol Health is minor and is not expected to be material to the combined company, the filing said.

The company is awaiting informal merger clearance from the competition watchdog, with the condition precedent expected to be satisfied in December, allowing the merger to be effective shortly thereafter, according to the filing.

Integral Diagnostics shares rose 2% in morning trade Monday, while Capitol Health shares were up more than 4%.

Price (AUD): $2.96, Change: $+0.06, Percent Change: +2.07%